Back to search

Switzerland· 53360028

Similasan Venen-Beschwerden, Globuli

A medicinal product containing aesculus hippocastanum (hab) d8, aristolochia clematitis (hab) d10, lycopodium clavatum (hab) d12, vipera berus (hab) d12 (hab sv, 5a), registered in Switzerland by Similasan AG and dispensed under Swissmedic category D.

Cat D (Swissmedic)

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedSimilasan Venen-Beschwerden, GlobuliATC—REGISTER NO.53360028PACKS LISTED0CHECKEDSeptember 12, 2026

The record

At a glance

Swissmedic (Switzerland)
Active substance
aesculus hippocastanum (HAB) D8, aristolochia clematitis (HAB) D10, lycopodium clavatum (HAB) D12, vipera berus (HAB) D12 (HAB SV, 5a)
Manufacturer
Similasan AG
Country
Switzerland (CH)
ATC code
—
Swissmedic category
D
Reimbursed
No
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f7563865-3592-4a6f-8148-231b31e0bece
GET /v1/drugs/f7563865-3592-4a6f-8148-231b31e0bece?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{}

See everything about aesculus hippocastanum (hab) d8, aristolochia clematitis (hab) d10, lycopodium clavatum (hab) d12, vipera berus (hab) d12 (hab sv, 5a).

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.